Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Pharmaceuticals has informed that it enclosed the Investor Presentation on JPMC Healthcare conference Jan 2025.
The above information is a part of company’s filings submitted to BSE.